Menu Close

Yet Another Delay for 340B Drug Pricing Program Rule

Posted in Hospitals and Institutions, Legislation and Public Policy, Medicare and Medicaid, Pharmaceuticals

On June 5, the Health Resources and Services Administration, part of the U.S. Department of Health and Human Services, published a final rule that further delays the effective date of the January 5, 2017 final rule on calculation of drug price ceilings and the imposition of civil monetary penalties for manufacturers that knowingly and intentionally overcharge covered entities under the 340B Drug Pricing Program.Implementation of the price ceiling rule, discussed in detail here, had already been postponed four times, most recently last August. The effective date of the rule will now be further delayed until July 1, 2019, “to allow a more deliberate process of considering alternative and supplemental regulatory provisions and to allow for sufficient time for any additional rulemaking.”

Leave a Reply

Your email address will not be published. Required fields are marked *